AAAAAA

   
Results: 1-14 |
Results: 14
A randomized prospective multicentre trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia
Authors: Bauduer, F Cousin, T Boulat, O Rigal-Huguet, F Molina, L Fegueux, N Jourdan, E Boiron, JM Reiffers, J
Citation: F. Bauduer et al., A randomized prospective multicentre trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia, LEUK LYMPH, 42(3), 2001, pp. 379-386
Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT study group
Authors: Jourdan, E Reiffers, J Stoppa, AM Sotto, JJ Attal, M Bouabdallaha, R Marit, G Fegueux, N Boulat, O Dastugue, N Boiron, JM Faberes, C Gastaut, JA Maraninchi, D Blaise, D
Citation: E. Jourdan et al., Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT study group, LEUK LYMPH, 42(1-2), 2001, pp. 57-65
Autologous peripheral blood stem cell transplantation following heart transplantation for primary systemic amyloidosis
Authors: Mohty, M Albat, B Fegueux, N Rossi, JF
Citation: M. Mohty et al., Autologous peripheral blood stem cell transplantation following heart transplantation for primary systemic amyloidosis, LEUK LYMPH, 41(1-2), 2001, pp. 221-223
Immunotherapy by non-myeloablative allogeneic stem cell transplantation inmultiple myeloma: results of a pilot study as salvage therapy after autologous transplantation
Authors: Garban, F Attal, M Rossi, JF Payen, C Fegueux, N Sotto, JJ
Citation: F. Garban et al., Immunotherapy by non-myeloablative allogeneic stem cell transplantation inmultiple myeloma: results of a pilot study as salvage therapy after autologous transplantation, LEUKEMIA, 15(4), 2001, pp. 642-646
Enhanced graft-versus-tumor effect following dose-reduced conditioning andallogeneic transplantation for refractory lymphoid malignancies after high-dose therapy
Authors: Mohty, M Fegueux, N Exbrayat, C Lu, ZY Legouffe, E Quittet, P Lopez-Martinez, E Latry, P Avinens, O Hertog, C Klein, B Eliaou, JF Rossi, JF
Citation: M. Mohty et al., Enhanced graft-versus-tumor effect following dose-reduced conditioning andallogeneic transplantation for refractory lymphoid malignancies after high-dose therapy, BONE MAR TR, 28(4), 2001, pp. 335-339
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia
Authors: Fenaux, P Chevret, S Guerci, A Fegueux, N Dombret, H Thomas, X Sanz, M Link, H Maloisel, F Gardin, C Bordessoule, D Stoppa, AM Sadoun, A Muus, P Wandt, H Mineur, P Whittaker, JA Fey, M Daniel, MT Castaigne, S Degos, L
Citation: P. Fenaux et al., Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia, LEUKEMIA, 14(8), 2000, pp. 1371-1377
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation
Authors: Thomas, X Dombret, H Cordonnier, C Pigneux, A Gardin, C Guerci, A Vekhoff, A Sadoun, A Stamatoullas, A Fegueux, N Maloisel, F Cahn, JY Reman, O Gratecos, N Berthou, C Huguet, F Kotoucek, P Travade, P Buzyn, A de Revel, T Vilque, JP Naccache, P Chomienne, C Degos, L Fenaux, P
Citation: X. Thomas et al., Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation, LEUKEMIA, 14(6), 2000, pp. 1006-1013
Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM)
Authors: Michallet, M Thomas, X Vernant, JP Kuentz, M Socie, G Esperou-Bourdeau, H Milpied, N Blaise, D Rio, B Reiffers, J Jouet, JP Cahn, JY Bourhis, JH Lioure, B Leporrier, M Sotto, JJ Souillet, G Sutton, L Bordigoni, P Dreyfus, F Tilly, H Gratecos, N Attal, M Leprise, PY Demeocq, F Michel, G Buzyn, A Delmas-Marsalet, B Bernaudin, F Ifrah, N Sadoun, A Guyotat, D Cavazzana-Cavo, M Caillot, D De Revel, T Vannier, JP Baruchel, A Fegueux, N Tanguy, ML Thiebaut, A Belhabri, A Archimbaud, E
Citation: M. Michallet et al., Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM), BONE MAR TR, 26(11), 2000, pp. 1157-1163
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial
Authors: de Botton, S Chevret, S Sanz, M Dombret, H Thomas, X Guerci, A Fey, M Rayon, C Huguet, F Sotto, JJ Gardin, C Makhoul, PC Travade, P Solary, E Fegueux, N Bordessoule, D San Miguel, J Link, H Desablens, B Stamatoullas, A Deconinck, E Geiser, K Hess, U Maloisel, F Castaigne, S Preudhomme, C Chomienne, C Degos, L Fenaux, P
Citation: S. De Botton et al., Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial, BR J HAEM, 111(3), 2000, pp. 801-806
Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia
Authors: Guardiola, P Kuentz, M Garban, F Blaise, D Reiffers, J Attal, M Buzyn, A Lioure, B Bordigoni, P Fegueux, N Tanguy, ML Vernant, JP Gluckman, E Socie, G
Citation: P. Guardiola et al., Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia, BR J HAEM, 111(1), 2000, pp. 292-302
Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)
Authors: Michallet, M Tanguy, ML Socie, G Thiebaut, A Belhabri, A Milpied, N Reiffers, J Kuentz, M Cahn, JY Blaise, D Demeocq, F Jouet, JP Michallet, AS Ifrah, N Vilmer, E Molina, L Michel, G Lioure, B Cavazzana-Calvo, M Pico, JL Sadoun, A Guyotat, D Attal, M Cure, H Bordigoni, P Sutton, L Buzyn-Veil, A Tilly, M Leporrier, M Fegueux, N Dreyfus, F Rio, B Lutz, P Vernant, JP
Citation: M. Michallet et al., Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM), BR J HAEM, 108(2), 2000, pp. 400-407
Thrombotic and necrotizing panniculitis associated with recombinant human granulocyte colony-stimulating factor treatment
Authors: Dereure, O Bessis, D Lavabre-Bertrand, T Exbrayat, C Fegueux, N Biron, C Guilhou, JJ
Citation: O. Dereure et al., Thrombotic and necrotizing panniculitis associated with recombinant human granulocyte colony-stimulating factor treatment, BR J DERM, 142(4), 2000, pp. 834-836
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia
Authors: Fenaux, P Chastang, C Chevret, S Sanz, M Dombret, H Archimbaud, E Fey, M Rayon, C Huguet, F Sotto, JJ Gardin, C Makhoul, PC Travade, P Solary, E Fegueux, N Bordessoule, D San Miguel, J Link, H Desablens, B Stamatoullas, A Deconinck, E Maloisel, F Castaigne, S Preudhomme, C Degos, L
Citation: P. Fenaux et al., A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia, BLOOD, 94(4), 1999, pp. 1192-1200
Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot study
Authors: Blaise, D Jourdan, E Michallet, M Jouet, JP Boiron, JM Michel, G Faucher, C Fegueux, N Schuller, MP Badri, N Chabannon, C Maraninchi, D
Citation: D. Blaise et al., Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot study, BONE MAR TR, 22(12), 1998, pp. 1153-1158
Risultati: 1-14 |